Your Article Summary
See Latest ArticlesEstimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: Setting an evidence-based benchmark for the best-quality cancer care
European Journal of Cancer, 06/23/09
Ng W et al. - The optimal proportion of patients who should receive chemotherapy in the head and neck carcinoma population has risen significantly over the past 20 years. This temporal rise does not appear to be reflected in the limited actual utilisation rates that are available for comparison.
Related Articles
Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas
European Journal of Surgical Oncology, 11/16/09
Relevance Score: 82%
Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
The Lancet Oncology, 11/02/09
Relevance Score: 82%
Papillary Squamous Cell Carcinoma of the Head and Neck: Frequent Association With Human Papillomavirus Infection and Invasive Carcinoma
American Journal of Surgical Pathology, 10/29/09
Relevance Score: 81%
Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer
Annals of Oncology, 10/20/09
Relevance Score: 81%
HER2 expression predicts improved survival in patients with cervical node–positive head and neck squamous cell carcinoma
Otolaryngology Head and Neck Surgery, 10/13/09
Relevance Score: 81%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Combined antegrade and retrograde esophageal dilation for head and neck cancer-related complete esophageal stenosis
The Laryngoscope, 12/10/09
Fascial Flap Reconstruction of the Hand: A Single Surgeons 30-Year Experience
Plastic and Reconstructive Surgery, 12/10/09
Role of surgical management in temporal bone fibrous dysplasia
Acta Oto-Laryngologica , 12/10/09